Good Day BIO: USDA nominee calls for 'science-based decison-making'

September 23, 2022
Ending the week with USDA nominee Alexis Taylor’s hearing at the Senate Ag Committee, BIO’s webinar on the impacts of the new drug price controls—and a deal on prescription drug user fees. Enjoy the weekend. (883 words, 4 minutes, 24 seconds)
Biotechnology Innovation Organization (BIO)
 
 
 
Join BIO at the Patient & Health Advocacy Summit in October - click for details.
 
 
BIO Beltway Report
Facebook
Twitter
LinkedIn
YouTube